Application of tert-butyl hydroquinone and drug for treating intervertebral disc degeneration
A technology of tertiary butyl hydroquinone and intervertebral disc, which is applied in the field of medicine to achieve good anti-oxidation effect and alleviate the effect of intervertebral disc degeneration
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0027] This embodiment provides a drug for treating intervertebral disc degeneration, which can be used for treating or delaying intervertebral disc degeneration. Specifically, the drug includes a drug carrier and tert-butyl hydroquinone; wherein, the drug carrier is a commercially available ethyl oleate microemulsion, and each g of the drug contains 0.2 g of tert-butyl hydroquinone. It should be noted that the preparation method of the drug does not belong to the improvement point of the present invention, and it can be prepared by existing common pharmaceutical processes, so it will not be described in detail here.
Embodiment 2
[0029] This embodiment provides a drug for treating intervertebral disc degeneration, which can be used for treating or delaying intervertebral disc degeneration. Specifically, the medicine includes a drug carrier and tertiary butyl hydroquinone; wherein, the drug carrier is a commercially available ethyl oleate microemulsion, and each g of the drug contains 0.3 g of tertiary butyl hydroquinone. It should be noted that the preparation method of the drug does not belong to the improvement point of the present invention, and it can be prepared by existing common pharmaceutical processes, so it will not be described in detail here.
Embodiment 3
[0031] This embodiment provides a drug for treating intervertebral disc degeneration, which can be used for treating or delaying intervertebral disc degeneration. Specifically, the drug includes a drug carrier and tert-butyl hydroquinone; wherein, the drug carrier is a commercially available ethyl oleate microemulsion, and each g of the drug contains 0.251 g of tert-butyl hydroquinone. It should be noted that the preparation method of the drug does not belong to the improvement point of the present invention, and it can be prepared by existing common pharmaceutical processes, so it will not be described in detail here.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com